Cite

HARVARD Citation

    Dedic, N. et al. (2023). TAAR1 Agonist Ulotaront Improves Glycemic Control and Reduces Body Weight in Rodent Models of Diabetes, Obesity, and Iatrogenic Weight Gain. CNS spectrums. p. 259. [Online]. 
  
Back to record